Article Details

Harbour BioMed Announces Approval for Phase I Trial of B7H4x4-1BB Bispecific Antibody ...

Retrieved on: 2022-02-28 04:18:51

Tags for this article:

Click the tags to see associated articles and topics

Harbour BioMed Announces Approval for Phase I Trial of B7H4x4-1BB Bispecific Antibody .... View article details on hiswai:

Excerpt

HBM7008 is generated from our unique and innovative HBICE® platform. ... The Company's proprietary antibody technology platforms Harbour Mice® ...

Article found on: www.prnewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up